Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
British Journal of General Practice
Intended for Healthcare Professionals

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Clinical Intelligence

The investigation of chronic diarrhoea: new BSG guidance

John Ong, Carla Swift, Roger Norman, Ian Allwood, Yasseen Al-Naeeb and Arun Shankar
British Journal of General Practice 2019; 69 (682): 262-264. DOI: https://doi.org/10.3399/bjgp19X702653
John Ong
Department of Engineering, Materials Engineering and Materials — Tissue Interactions Group, University of Cambridge, Cambridge; East of England Gastroenterology Speciality Training Programme, Cambridge.
Roles: Specialist registrar and doctoral fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla Swift
Department of Gastroenterology, Bedford Hospital NHS Trust, Bedford.
Roles: Specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Norman
Asplands Medical Centre and Woburn Surgery, Milton Keynes.
Roles: GP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Allwood
Bridge House Medical Centre, Stratford-upon-Avon.
Roles: GP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasseen Al-Naeeb
Department of Gastroenterology, Bedford Hospital NHS Trust, Bedford.
Roles: Consultant gastroenterologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arun Shankar
Department of Gastroenterology, Norfolk and Norwich University Hospital NHS Trust, Norwich.
Roles: Consultant gastroenterologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading

This article has a correction. Please see:

  • Correction - September 01, 2019

INTRODUCTION

Chronic diarrhoea has an estimated prevalence of about 4–5% in Western populations and is one of the most common reasons for gastroenterology referral.1 There is a myriad of causes for chronic diarrhoea, which can make the investigation and diagnosis of the underlying cause difficult. In 2003, the British Society of Gastroenterology (BSG) released guidelines2 to aid in the investigation of chronic diarrhoea; however, these have since been updated, in April 2018. Below, we provide a brief and focused summary of the new 2018 guidelines1 for primary care, highlight the new changes compared with the 2003 edition, and discuss some limitations of the new guidance.

CLINICAL ASSESSMENT IN PRIMARY CARE

Initial investigations in primary care are aimed at differentiating organic gastrointestinal (GI) disease from functional disease. Routine, screening blood tests are recommended in all patients presenting with chronic diarrhoea, and these include full blood count, ferritin, c-reactive protein, coeliac serology, and thyroid function tests. Faecal calprotectin (FCP) is now recommended as a screening tool to detect inflammatory causes of chronic diarrhoea, and stool cultures remain useful in distinguishing infection from other inflammatory causes of chronic diarrhoea. Faecal immunochemical testing (FIT) is a new method of detecting the presence of blood in faeces and can be used instead of the traditional faecal occult blood test (FOBT) where available.

In general, for patients with typical symptoms of functional bowel disease, normal physical examination, and normal screening investigations, a diagnosis of IBS can be made. However, referral should be considered for those with abnormal screening investigations or persistent symptoms that impact the quality of life and do not respond to initial treatment.

The main new guideline changes impacting primary care physicians are as follows:

  • Change in definition: chronic diarrhoea is now defined as ‘the persistent alteration from the norm with stool consistency between types 5 and 7 on the Bristol stool chart and increased frequency greater than 4 weeks’ duration’. Stool weight and daily stool frequency have been abandoned due to limited clinical value.

  • The use of FCP to exclude inflammation within the gut: in chronic diarrhoea where cancer is not suspected, it is now recommended that FCP should be tested in adults <40 years of age. Further guidance on interpreting abnormal FCP results and their management can be found in a recently published NHS England document, which has been endorsed by the National Institute for Health and Care Excellence (NICE).3

  • The use of FIT to detect colonic cancer: in patients with chronic diarrhoea suspicious of colonic cancer and without rectal bleeding, FIT is now recommended as a rule-out test to guide further investigations. There will be a move away from the older FOBT because FIT has a better diagnostic performance.

  • Dual-method testing for Clostridium difficile (C. diff): glutamate dehydrogenase enzyme immunoassay (EIA) or polymerase chain reaction, in combination with toxin assays, is now recommended for the diagnosis of C. diff. The combination provides higher negative and positive predictive values.

  • Recommendations for immunocompromised patients: consideration should be given to the possibility of immunodeficiency states presenting as chronic diarrhoea. If immunodeficiency is suspected, testing for human immunodeficiency virus (HIV) is recommended. If immunodeficiency is already established, norovirus or cryptosporidia should be excluded through stool testing.

  • Recommendations on anorectal disease: physicians are reminded to be vigilant for faecal impaction with overflow diarrhoea, especially in older people. In cases of faecal incontinence where conservative measures fail, it is recommended that patients be offered anorectal manometry and endoanal ultrasonography. Cross-sectional imaging with contrast is recommended if a fistula is suspected.

NEW CHANGES IN SECONDARY CARE INVESTIGATIONS THAT COULD AFFECT PRIMARY CARE

  • Younger age limits for lower GI endoscopy: If endoscopy is indicated, colonoscopy with ileoscopy and biopsy is now the preferred investigation without limitations in patient age; this was previously reserved for patients aged >45 years. However, in patients aged <40 years with functional symptoms, normal FCP, and in whom functional bowel disease is suspected, flexible sigmoidoscopy with biopsy is now recommended (previously for <45 years in age with atypical symptoms).

  • SeHCAT (tauroselcholic [75 selenium] acid) or fasting serum C4 (7α hydroxy-4-cholesten-3-one) testing are now recommended in patients with suspected functional diarrhoea: one in three patients with diarrhoea-predominant irritable bowel syndrome (IBS-D) has bile salt malabsorption. It is recommended that patients with SeHCAT value <15% or elevated C4 levels be trialled on a course of bile salt sequestrants. Empirical therapy may be trialled if both tests are unavailable.

  • Hydrogen breath testing or withdrawal of dietary lactose are now recommended if lactose maldigestion is suspected: no recommendations were made in the previous version.

  • Magnetic resonance imaging (MRI) enterography/enteroclysis or video capsule endoscopy are now the preferred imaging modalities to investigate small bowel disease: if both are unavailable, computed tomography (CT) may be used. Small bowel barium follow through and barium enteroclysis are no longer recommended due to poor sensitivity and specificity.

  • Glucose and lactulose breath tests are no longer indicated for the investigation of small bowel bacterial overgrowth (SBBO): this is due to the low sensitivity and specificity of these tests. Small bowel aspirates are recommended as the gold standard of diagnosis of SBBO. However, if this is not possible, empirical antibiotic therapy is recommended.

  • Faecal elastase is recommended to diagnose pancreatic insufficiency, and MRI (with magnetic resonance cholangio-pancreatography [MRCP] protocol) is recommended to diagnose chronic pancreatitis: CT is an alternative if MRI is not possible. If these investigations are normal, but the clinical suspicion remains high, endoscopic ultrasound (EUS) or MRCP with secretin is recommended.

  • Biopsies from the left and right colon should be taken to exclude microscopic colitis: microscopic colitis, a common cause of chronic diarrhoea in patients aged >50 years, often has a patchy distribution. Therefore one-sided colonic biopsies are no longer recommended.

LIMITATIONS

The main limitation of the new guidelines that is most relevant and impactful to primary care is the ambiguity surrounding recommendations for endoscopy. The new guidelines recommend: ‘In patients with typical symptoms of functional bowel disease, normal physical examination and normal screening blood and faecal tests (calprotectin), a positive diagnosis of IBS can be made.’

However, within the same set of recommendations it states: ‘In younger patients (<40 years) with a normal faecal calprotectin and in whom functional bowel disease is suspected, we recommend a flexible sigmoidoscopy.’

This was subsequently clarified with the authors,4 and in the latter group of younger patients (<40 years) they have recommended secondary care evaluation for patients with atypical, persisting, or severe symptoms of functional bowel disease5 even if the FCP is normal. Therefore, primary care physicians need not refer such patients for lower GI investigations directly but should refer these patients for specialist review in secondary care.

SUMMARY

Significant changes have been made to the previous guidelines that will undoubtedly improve the investigation of chronic diarrhoea in the community. A summarised flow diagram (Figure 1) has been created for physicians at the point of care for ease of use.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Flow diagram for the investigation of chronic diarrhoea in primary care based on the 2018 BSG guidelines1and NICE recommendations.3aUrgent clinical review and referral to gastroenterology if FCP >250 μg/g on repeat sample or if acute severe IBD is suspected. BSG = British Society of Gastroenterology. FCP = faecal calprotectin. FIT = faecal immunochemical testing. GI = gastrointestinal IBD = inflammatory bowel disease. IBS = irritable bowel syndrome. NICE = National Institute for Health and Care Excellence. SeHCAT = tauroselcholic [75 selenium]acid

Acknowledgments

John Ong was supported by the WD Armstrong Doctoral Fellowship from the University of Cambridge. Communications and access to literature were supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, and the University of Cambridge. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.

Notes

Funding

None.

Provenance

Freely submitted; externally peer reviewed.

Competing interests

The authors have declared no competing interests.

Discuss this article

Contribute and read comments about this article: www.bjgp.org/letters

  • Received December 10, 2018.
  • Revision requested December 14, 2018.
  • Accepted December 20, 2018.
  • © British Journal of General Practice 2019

REFERENCES

  1. 1.↵
    1. Arasaradnam RP,
    2. Brown S,
    3. Forbes A,
    4. et al.
    (2018) Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut doi:10.1136/gutjnl-2017-315909.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Thomas PD,
    2. Forbes A,
    3. Green J,
    4. et al.
    (2003) Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 52(Suppl 5):v1–v15.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Chief Scientific Officer, Faecal Calprotectin Working Group, NHS England
    (2018) Faecal calprotectin in primary care as a decision diagnostic for inflammatory bowel disease and irritable bowel syndrome, https://www.nice.org.uk/guidance/dg11/resources/endorsed-resource-consensus-paper-pdf-4595859614 (accessed 5 Apr 2019).
  4. 4.↵
    1. Ong J,
    2. Swift C,
    3. Allwood I,
    4. et al.
    (2018) Chronic diarrhoea: the indications of lower GI endoscopy when functional bowel disease is suspected. Gut doi:10.1136/gutjnl-2018-317574.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Arasaradnam RP,
    2. Walters JRF
    (2018) Role of endoscopy in chronic diarrhoea when functional bowel disease is suspected. Gut doi:10.1136/gutjnl-2018-317730.
    OpenUrlFREE Full Text
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 69 (682)
British Journal of General Practice
Vol. 69, Issue 682
May 2019
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The investigation of chronic diarrhoea: new BSG guidance
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The investigation of chronic diarrhoea: new BSG guidance
John Ong, Carla Swift, Roger Norman, Ian Allwood, Yasseen Al-Naeeb, Arun Shankar
British Journal of General Practice 2019; 69 (682): 262-264. DOI: 10.3399/bjgp19X702653

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The investigation of chronic diarrhoea: new BSG guidance
John Ong, Carla Swift, Roger Norman, Ian Allwood, Yasseen Al-Naeeb, Arun Shankar
British Journal of General Practice 2019; 69 (682): 262-264. DOI: 10.3399/bjgp19X702653
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • INTRODUCTION
    • CLINICAL ASSESSMENT IN PRIMARY CARE
    • NEW CHANGES IN SECONDARY CARE INVESTIGATIONS THAT COULD AFFECT PRIMARY CARE
    • LIMITATIONS
    • SUMMARY
    • Acknowledgments
    • Notes
    • REFERENCES
  • Figures & Data
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • How to manage low testosterone level in men: a guide for primary care
  • Hyperparathyroidism (primary) NICE guideline: diagnosis, assessment, and initial management
  • The atypical presentation of COVID-19 as gastrointestinal disease: key points for primary care
Show more Clinical Intelligence

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2023 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242